Cargando…
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
About 5-10% of breast and ovarian carcinomas are hereditary and most of these result from germline mutations in the BRCA1 and BRCA2 genes. In women of Ashkenazi Jewish ascendance, up to 30% of breast and ovarian carcinomas may be attributable to mutations in these genes, where 3 founder mutations, c...
Autores principales: | Ewald, Ingrid P, Izetti, Patrícia, Vargas, Fernando R, Moreira, Miguel AM, Moreira, Aline S, Moreira-Filho, Carlos A, Cunha, Danielle R, Hamaguchi, Sara, Camey, Suzi A, Schmidt, Aishameriane, Caleffi, Maira, Koehler-Santos, Patrícia, Giugliani, Roberto, Ashton-Prolla, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313847/ https://www.ncbi.nlm.nih.gov/pubmed/22185575 http://dx.doi.org/10.1186/1897-4287-9-12 |
Ejemplares similares
-
Haplotypic characterization of BRCA1 c.5266dupC, the
prevailing mutation in Brazilian hereditary breast/ovarian
cancer
por: Gomes, Renan, et al.
Publicado: (2020) -
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care
por: Ashton-Prolla, Patricia, et al.
Publicado: (2009) -
Screening for germline BRCA1, BRCA2,
TP53 and CHEK2 mutations in families at-risk for
hereditary breast cancer identified in a population-based study from Southern
Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2016) -
Genomic rearrangements in BRCA1 and BRCA2: A literature review
por: Ewald, Ingrid Petroni, et al.
Publicado: (2009) -
Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil
por: Palmero, Edenir I., et al.
Publicado: (2009)